Patents by Inventor Anders Wallqvist

Anders Wallqvist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11371097
    Abstract: Disclosed are methods and articles (e.g., gene arrays or antibodies) for determining the progression or regression of liver fibrosis, for the diagnosis of liver disease, and for screening compounds for hepatotoxicity and efficacy against liver fibrosis. Related therapeutic methods also are disclosed.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: June 28, 2022
    Assignee: The Government of the United States, as represented by the Secretary of the Army
    Inventors: Mohamed Diwan M. Abdulhameed, Gregory J. Tawa, Danielle L. Ippolito, John A. Lewis, Sven Anders Wallqvist, Jonathan D. Stallings, Matthew G. Permenter
  • Patent number: 11345653
    Abstract: The invention relates to compounds, compositions and methods for activating, reactivating, reversing or preventing the deactivation of cholinesterases, such as acetylcholinesterase and butyrylcholinesterase.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: May 31, 2022
    Assignees: The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., The Government of the United States as Represented by the Secretary of the Army
    Inventors: Ilja Khavrutskii, Sven Anders Wallqvist
  • Publication number: 20190345097
    Abstract: The invention relates to compounds, compositions and methods for activating, reactivating, reversing or preventing the deactivation of cholinesterases, such as acetylcholinesterase and butyrylcholinesterase.
    Type: Application
    Filed: June 16, 2017
    Publication date: November 14, 2019
    Applicants: The Henry M. Jackson Foundation for the Advancemen t of Military Medicine, Inc., The Government of the United States as Represented by the Secretary of the Army
    Inventors: Ilja Khavrutskii, Anders Wallqvist
  • Publication number: 20180023140
    Abstract: Disclosed are methods and articles (e.g., gene arrays or antibodies) for determining the progression or regression of liver fibrosis, for the diagnosis of liver disease, and for screening compounds for hepatotoxicity and efficacy against liver fibrosis. Related therapeutic methods also are disclosed.
    Type: Application
    Filed: January 29, 2016
    Publication date: January 25, 2018
    Inventors: Mohamed Diwan M. ABDULHAMEED, Gregory J. TAWA, Danielle L. IPPOLITO, John A. LEWIS, Anders WALLQVIST, Jonathan D. STALLINGS, Matthew G. PERMENTER
  • Patent number: 7625917
    Abstract: This invention pertains to the discovery of a novel family of thiolesters and uses thereof. Also provided for are viricidal compounds and pharmaceutical formulations comprising these novel thiolesters. The invention also provides thiolester-inactivated viruses and thiolester-complexed viral proteins.
    Type: Grant
    Filed: December 16, 2003
    Date of Patent: December 1, 2009
    Inventors: James A. Turpin, Yongsheng Song, Ettore Appella, John K. Inman, David G. Covell, William G. Rice, Anders Wallqvist, Andrew Maynard, Mingjun Huang
  • Publication number: 20040132785
    Abstract: This invention pertains to the discovery of a novel family of thiolesters and uses thereof. Also provided for are viricidal compounds and pharmaceutical formulations comprising these novel thiolesters. The invention also provides thiolester-inactivated viruses and thiolester-complexed viral proteins.
    Type: Application
    Filed: December 16, 2003
    Publication date: July 8, 2004
    Applicant: The Government of the U. S.of America as Represented by The Sec. of Health and Human Svc.
    Inventors: James A. Turpin, Yongsheng Song, Ettore Appella, John K. Inman, David G. Covell, William G. Rice, Anders Wallqvist, Andrew Maynard, Mingjun Huang
  • Patent number: 6706729
    Abstract: This invention pertains to the discovery of a novel family of thiolesters and uses thereof. Also provided for are viricidal compounds and pharmaceutical formulations comprising these novel thiolesters. The invention also provides thiolester-inactivated viruses and thiolester-complexed viral proteins.
    Type: Grant
    Filed: May 16, 2001
    Date of Patent: March 16, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: James A. Turpin, Yongsheng Song, Ettore Appella, John K. Inman, David G. Covell, William G. Rice, Anders Wallqvist, Andrew Maynard, Mingjun Huang